UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025637
Receipt number R000029496
Scientific Title Information therapy using inaudible sounds for substance use disorders
Date of disclosure of the study information 2017/01/12
Last modified on 2019/05/14 22:06:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Information therapy using inaudible sounds for substance use disorders

Acronym

Information therapy for substance use disorders

Scientific Title

Information therapy using inaudible sounds for substance use disorders

Scientific Title:Acronym

Information therapy for substance use disorders

Region

Japan


Condition

Condition

Substance use disorders

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of information therapy using inaudible sounds for substance use disorders.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Change from the baseline by the OCDS (Obsessive Compulsive Drinking Scale) scores after 8-week information therapy

Key secondary outcomes

Change from the baseline by the following items
1.ACQ-SF-R (Alcohol Craving Questionnaire Short Form Revised) score
2.The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)
3.AUDIT(The Alcohol Use Disorders Identification Test)
4.Medication

Following items in relation to safety
5. Attrition rate of any cause
6. All adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Exposure of inaudible sounds for 8 weeks during cognitive behavioral therapy sessions

Interventions/Control_2

Exposure of audible sounds for 8 weeks during cognitive behavioral therapy sessions

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

-Patients who meet criteria of substance use disorders by DSM-5
-Inpatients/outpatients of the Kurihama Medical and Addiction Center
-Patients who completed detoxification therapy, in case they are inpatients

Key exclusion criteria

-In case they have history of developmental disorder, bipolar disorder or schizophrenia.
-In case they are evaluated as insufficient for providing informed consent
-In case they are evaluated as not appropriate for enrolling in the study by attending physician.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Honda

Organization

National Center of Neurology and Psychiatry

Division name

Department of Functional Brain Research, National Institute of Neuroscience

Zip code

187-8502

Address

4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan

TEL

042-346-1718

Email

honda@ncnp.go.jp


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Yamashita

Organization

National Center of Neurology and Psychiatry

Division name

Department of Functional Brain Research, National Institute of Neuroscience

Zip code

187-8502

Address

4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan

TEL

042-346-1718

Homepage URL


Email

yamay@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

National Center of Neurology and Psychiatry

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center of Neurology and Psychiatry Ethics Committee

Address

4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan

Tel

048-462-1111

Email

ml_rinrijimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 09 Month 08 Day

Date of IRB

2016 Year 08 Month 26 Day

Anticipated trial start date

2017 Year 01 Month 12 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 01 Month 12 Day

Last modified on

2019 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029496


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name